Home / News / Pearce IP Blog
Date: 02 June 2021Forum: Australian Patent OfficeDelegate: Damian Triffett Background In June 2021, the Australian...
At the end of 2020, we reported on a Government review of the Australian patent system and its accessibility for small...
24 May 21 | IN | Zydus Cadila announced it has launched Ujvira (trastuzumab emtansine) in India. Ujvira is an antibody...
12 May 21 | Celltrion released its Q1 2020 financial results, reporting that YoY sales of Celltrion biosimilars...
11 May | US | Alvotech filed a federal lawsuit against AbbVie in the US District Court of the Eastern District of...
On 11 May 2021, Treasurer Josh Frydenberg announced that the 2021-2022 Australian Federal Budget would introduce a...
01 May 21 | Samsung Bioepis announced a new study demonstrating the structural, physicochemical and biological...
Date: 5 May 2021Court: Full Court of the Federal Court of AustraliaJudges: Beach, Moshinsky and Thawley JJ Background...
In light of the COVID-19 vaccine supply shortages in Australia, it was refreshing to hear NSW Premier Gladys...
23 April | Boehringer Ingelheim announced results from a Ph III switching study of Cyltezo® (biosimilar adalimumab)...
Date: 27 April 2021Court: Federal Court of AustraliaJudge: Yates J Background In March 2012, Otsuka Pharmaceutical...
15 April 21 | US | The Centre for Biosimilars reported a poster presented at AMCP 2021 shows a New York state Medicaid...
Recent decisions of the Australian Federal Court reinforce the need for exclusive patent licences to include all...
13 April 2021 | Purple Biotech announced it presented further preclinical data supporting the mechanism of action of...
06 April 2021 | PlantForm announced it has reached a collaborative research and development agreement with...
29 March 2021 | Samsung Bioepis announced on 29 March 2021 that it has launched Hadlima®, its 50mg/mL biosimilar...